Table 2.

Laboratory results for 122 patients with differentiated thyroid cancer.

Tests	With recurrence (n = 12)	Without recurrence (n = 110)	P
Thyroglobulin (ng/mL)	0.13 (0.00–5.60)	0.00 (0.00-0.10)	0.026
Positive anti-thyroglobulin Ab (number)	0 (0.0)	3 (2.7)	1.000
Triiodothyronine (ng/mL)a	1.0 (0.8–1.2)	1.0 (0.9–1.1)	0.781
Free thyroxine (ng/mL)	1.8 (1.4–1.8)	1.6 (1.4–1.8)	0.355
Thyroid-stimulating hormone (mIU/mL)	0.2 (0.0–0.7)	0.1 (0.0–0.4)	0.273
Absolute neutrophil count (/µL)	3537 (2808–4624)	3192 (2731–3903)	0.298
Neutrophil elastase (ng/mL)	116.7 (50.1–445.1)	35.9 (28.4–73.2)	0.014
Histone–DNA complex (AU)	125.0 (52.0–319.5)	82.0 (50.0–156.0)	0.624
Cell-free dsDNA (ng/mL)	99.0 (84.2–126.8)	89.7 (76.4–119.1)	0.206
Activated factor XII (U/L)	33.3 (22.1–59.5)	31.3 (25.2–54.1)	0.901
Endogenous thrombin potential (nM · min)	1532.9 (1444.2–1727.3)	1511.3 (1381.0–1721.4)	0.502

Numbers are presented as median (interquartile range) or number of patients (percentages).

^aTriiodothyronine level was not measured in five patients without recurrence.

Ab, antibody; ds, double-stranded.